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Abstract
Neurosteroids like 3α-OH-5α-pregnan-20-one (allopregnanolone) and 3α-OH-5β-pregnan-20-one (pregnanolone)
modulate the γ-aminobutyric acid-A (GABAA) receptor function and produce several effects that can be considered
for therapeutical pruposes like antidepressant and anxiolyticts, in a similar way to benzodiazepines. However, their
rapid metabolism is a great disadvantage for medicinal treatments consideration. Synthetic steroid analogues with
more bioavailability and stability arise like a solution to overcome these limitations. In previous studies, we evaluated
the performance of a synthetic steroid group (Epoxies, similar to allopregnanolone and pregnanolone) throughout
different assays in rat cerebral cortex and hippocampus, including neuroprotection and GABAA receptor modulation
obtaining promising results. Taking into account the anxiolytic effect of allopregnanolone and pregnanolone, in this
work we evaluated the effect of an intracranial administration (in dorsal hippocampus) of two synthetic steroids,
Epoxy 1 and Epoxy 2, in an anxiety animal model to provide knowledge about the possible in vivo effects of these
steroids. Allopregnanolone and pregnanolone produced increases in vertical and horizontal exploration behaviors,
interpreted as anxiolytic-like effects. However, the two Epoxies capable to modulate GABAA receptor binding have
no effect on anxiety at the dose evaluated. These features make them suitable for other therapeutical purposes
where the anxiogenic behaviors are not involved.
Keywords: Neurosteroids; Synthetic analogues; Allopregnanolone;
Pregnanolone; Open field
Introduction
Inside the central nervous system, the in situ synthesized steroids
(neurosteroids, NS) are capable of modify the brain excitability [1,2].
Due to their chemical structure, the steroids may produce positive or
negative modulations over receptors, like the γ-aminobutyric acid-A
(GABAA) receptor [3,4]. Among the positive modulators of this
receptor are two progesterone’s metabolites: the 5α-pregnane-3α-ol-20-
one (allopregnanolone, A) and its isomer 5α-pregnane-3β-ol-20-one
(pregnanolone, P) [5]. In the last decades, the relevance of NS, like A
and P, also has been increasing due to their multiple roles in normal
and pathological behavior, ageing processes, damaged tissue
regeneration and neuroprotection [6-9].
The interest on these steroids arises specifically from their potential
activity as anticonvulsants, anesthetics, anxiolytic or sedative-hypnotic
agents [10] useful for the treatment of several neurological and
psychiatric disorders [5]. But, the main limitation for the therapeutical
administration of these NS is their rapid in vivo biotransformation to
other metabolites. Therefore, synthetic steroids (SS) analogues with
better bioavailability and efficacy have an important therapeutic
potential in brain disorders, becoming an alternative approach for
different pathologies [11,12].
In the last decades, a significant increase around NS physiology and
synthetic analogues development has been observed. The medicinal
chemistry of neuroactive steroids (NAS) has been focused in the
development of SS analogues preserving the absolute configuration of
naturally occurring steroids. Structure/activity studies of the
progesterone metabolites, indicate that the 3α-hydroxyl configuration
is required for binding and activity maintenance [13], while
modifications in some carbon atoms do not affect their functions
[14-16]. In previous works we evaluated the performance of a SS group
Epoxies (similar to A and P) through different assays as well as
neuroprotection and inhibition/stimulation binding of specific ligands
of the GABAA receptor in rat cerebral cortex and hippocampus
[17,18]. The main feature of these Epoxies is the presence of an oxygen
bridge that holds the A/B angle of steroidal nucleus in a controlled way,
conferring conformational restricted analogues [19]. In those studies,
we demonstrated that, of all the Epoxies tested, the Epoxy 1 (3α-
hydroxy-2β,19-epoxy-5α-pregnan-20-one; A analogue) and the Epoxy
2 (3α-hydroxy-6,19-epoxypregn-4-ene-20-one; P analogue) produced
the most similar effects to A and P [17,18].
On the other hand, severe psychiatric conditions like anxiety and
stress-related disorders affect daily performance in tasks and represent
a high cost to public health. Thus, the search of new and improve
therapeutical alternatives remains currently. Also, the fact that
neurosteroidogenic agents lack benzodiazepine-like side effects shows
promise in the treatment of anxiety and depression [11].
Administration of A or P produces anxiolytic, ataxic, hypnotic-
anesthetic and anticonvulsant effects as well as locomotor stimulation
[5,20-30], being able to mimic the actions of benzodiazepines. Taking
into account their effects as modulators of the GABAA receptor-ion-
channel complex [5] mentioned before, the mechanism underlying
their anxiolytic properties appears to be due to a potentiation of neural
inhibition via this receptor [31-34]. Previous studies suggest that A
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increases the channel conductance of GABAA receptor-gated Cl- in
hippocampal neurons, promoting anxiolytic-like effects [35-37]. This
supports the hypothesis about the role that the dorsal (CA1)
hippocampus area plays in emotional processes and NS modulation of
anxiety and exploration. It has also been postulated that the dorsal
region of this brain structure is involved in memory-related functions,
whereas the ventral region mediates fear and anxiety responses[38]. In
contrast to these anatomical and functional considerations, the recent
results of Mòdol et al. [39] demonstrate that the dorsal (CA1) area of
the hippocampus is also implicated in the modulation of anxiety-
related behaviors. Their studies indicate that the hippocampal
administration of A produces an anxiolytic-like profile and also
increases exploratory behavior, observed trough the enhancement of
the number of entries into the open arms in the elevated plus-maze
device. This suggests that CA1 region together with other brain
structures (such as the amygdala or the medial septum) could be an
important target for explaining the NS effects on exploration, anxiety,
learning and memory [39]. P administration in the dorsal
hippocampus or in the lateral septum also produces dose-dependent
anxiolytic-like effects in several animal models [36]. Moreover, both
steroids have shown a comparable potency eliciting anxiolytic effects
[24,27,31]. In addition, the ability of these and other NS to decrease
anxiety-induced behavior has been demonstrated in several tests such
as light/dark transition, rearing events and open-field [22,34,40]. In
fact, there is evidence that the anxiolytic action of progesterone is
mediated by its reduced metabolites, A and P [41,42]. Based in the
previous results obtained with the Epoxies in the GABAA receptor
modulation and the neuroprotective actions [17,18], and the
anxiolytic-like effects mediated by A and P, the aim of this work was to
evaluate the effects of two of these SS (Epoxy 1 and Epoxy 2)
administration over the animal behavior. These analysis were
performed in an anxiety model (open-field test), assessing horizontal
and vertical exploration and the anxiolytic-like effects; comparing
results between synthetic and natural steroids.
Materials and Methods
Steroids
Two natural steroids (A and P) and two synthetic analogues, 3α-
hydroxy-1β,11α-epoxy-5α-pregnan-20-one (Epoxy 1, A analogue) [43]
and 3α-hydroxy-6,19-epoxypregn-4-ene-20-one (Epoxy 2, P analogue)
[44] were used. Steroid concentration used for microinfusion (6.7
µg/µl) was selected according to our previous results [17,18]. The
solutions were prepared using cyclodextrin 30% in artificial
cerebrospinal fluid (aCSF) as vehicle one hour before the
administration.
Experimental animals
Ninety day old adult male Sprague Dawley rats (400 g; n=48) were
housed under standard laboratory conditions with a 12-h light-dark
cycle, with food and water ad libitum on a temperature (21ºC) and
humidity (40-70%) controlled vivarium. The animal surgical
procedures and treatments were evaluated by the Ethics Committee of
the Instituto de Biología y Medicina Experimental (IBYME), CABA,
Argentine, and approved according to the described on the protocol
CE 040-Jun/2014, in accordance with guidelines defined by the
European Community Council Directive (86/609/EEC) and the
National Institutes of Health Guide for the Care and Use of Laboratory
Animals.
Male rats were anesthetized with ketamine-xylazine (40:4 mg/Kg
i.p.; Holliday, Richmond, Argentina) and placed in a stereotaxic
apparatus (David Kopf Instruments, Tujunga CA, USA). Handmade
23-gauge stainless steel cannulae with 30-gauge removable inserts
(dummy cannulae) were unilaterally implanted on the dorsal
hippocampus using flat skull coordinates (anteroposterior, -2.3 mm;
mediolateral, ± 1.6 mm; dorsoventral, 2.8 mm; from Bregma)
according to the atlas Paxinos and Watson [45]. Three stainless steel
screws and dental cement were used to fix the cannulae to the skull
surface. After the surgery, animals were subcutaneously injected with a
nonsteroidal anti-inflammatory (Meloxican 2 mg/Kg body weight,
Boehringer Ingelheim, Argentina). A painkiller (Tramadol
chlorhydrate 0.15 g/L; Finadiet SACIFI, Argentina) and an antibiotic
(Enrofloxaxine 5 mg/L; Afford SA, Argentina) were administered in
the drinking water for the next 3 days.
Bilateral implants in some brain areas have been widely used to
explore the anxiolytic and/or antidepressant like-effects [46-48].
Although, the choice of unilateral cannulation (with left/right
alternations) performed in this work, was based in previous reports
that described anxiolytic and antidepressant effects with unilateral
microinjections of A [49] or progesterone [50], without behavioral
differences between brain sides.
Microinfusion procedure
Animals were allowed to recover for 10 days before performing the
behavioral trials. Vehicle (cyclodextrin 30% in aCSF) or steroids (A, P,
Epoxy 1 and Epoxy 2; 2 µg) were administered in 0.3 µl using a 30-
gauge injection needle connected by PC-40 tubing (Rivero SA,
Argentina) to a 10 µl glass syringe (Hamilton, Reno NV, USA; 0.1 µl/
min). After the 3 minutes of microinfusion, the injection needle was
kept in place for 1 additional minute to allow diffusion away from the
cannula tip before the dummy cannula reposition. According to the
condition, 5 groups of animals (n=8) were established: Vehicle
(cyclodextrin 30% in aCSF treatment), A (A treatment), P (P
treatment), Epoxy 1 (Epoxy 1 treatment) and Epoxy 2 (Epoxy 2
treatment). Animals were hand restrained during all microinfusion
procedure.
Behavioral testing
The open-field task [51,52] was used in accordance with the
methods described by McCarthy et al. [53]. Behavioral testing
occurred between 10:00 and 15:00h. The open-field device (housed in a
dimly lit room with controlled temperature 21ºC and humidity
40-70%) consisted of 75 cm side squared box divided in 25 quadrants,
with 30 cm height walls and an open roof. All animals were allowed to
explore the device for 15 minutes (precondition test) one day before
steroids microinfusion. At the next day, one minute after the dummy
cannula relocation, animals were placed in the center of the device and
were allowed to explore it for 300 seconds. The animal activity was
videotaped with a digital camera suspended above the test apparatus.
The behavioral parameters evaluated were: Freezing (duration of the
animal in a completely stationary state), Active time (determined as
total time test minus Freezing time), Line Crossing (number of grid
lines crossed with all four paws), the frequency and duration of
Grooming (when the animal licks and/or scratches itself while it stays
still) and Rearing (when the animal stands up on its hind legs). After
each trial, the apparatus was thoroughly cleaned with damp and dry
towels to prevent olfactory cues. Behavioral videos were scored by two
observers who were blind to the rat’s treatment condition.
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Histology
At the end of the behavioral testing period, animals were rendered
unconscious by CO2 and killed by decapitation. The brains were
removed, frozen and stored at -80ºC. Coronal sections (40 µm thick)
obtained with a cryostat were mounted on subbed slides and stained
with cresyl violet [54] for microscopic visualization of cannulae
placements. The results from animals with accurately placed cannulae
were used for the statistical analyses.
Statistical analysis
Statistical analyses were performed with commercial softwares
GraphPad Prism (Graphpad Software Inc., v.4) and Statview (SAS
Institute Inc. v5.0.1). The effects of intracranial microinfusions on the
behavioral parameters were analyzed by a one-way ANOVA and
comparisons between each steroid and vehicle were made by Newman-




Cannulae tip localizations in the brain from those animals used for
statistical analyses are schematically represented in Figure 1a. They
were mainly placed on the dorsal (CA1) area of the hippocampus
throughout the rostral-caudal extent. Cresyl violet staining was used
for the visualization (Figure 1b). Cannulae distribution was more
frequently positioned in -2.40 mm anteroposterior; 1.3 and 2.4 mm
mediolateral (left or right sides) and 2.6 mm dorsoventral from
Bregma (Figure 1c; Paxinos and Watson [45]). Animals with bad
placed cannulae (n=8) were discarded for statistical analyses.
Figure 1: a Schematic representation of the well placed point of injection illustrating cannulae tip localizations throughout the rostral-caudal
extent of the CA1 area of the hippocampus (anteroposterior, -2.3 mm; mediolateral, ± 1.6 mm; dorsoventral, 2.8 mm; from Bregma). Each
symbol refers to different anteroposterior distance from Bregma according to Paxinos and Watson Atlas (1998; ○:n=11; ∆:n=19;   :n=10). b
Representative photomicrographs of half coronal section, cresyl violet-stained, showing unilateral cannulae tip placements (left or right;
magnification x2). c Cannulae distributions according to dorsoventral (D-V) and mediolateral (LAT) distance in mm.
Active time
The amount of time in which animals were in activity was
determined as the total time of the test (300 sec) minus the Freezing
time (when the animals remain completely immobile). A significant
increase on Active time was observed with A and P treatments
compared to control (143% and 147% respectively; p<0.05). These
increases can be translated as an augmentation in total locomotor
activity and horizontal and vertical explorations (Figure 2a). Although,
no effects were observed with Epoxy 1 and Epoxy 2 treatments.
Line crossing
Ambulation was quantified as the number of grid lines crossed with
all four paws within the 300 sec of testing. A and P administrations
produced significant increases of this parameter compared to vehicle
(114% and 136% respectively; p<0.05; Figure 2b). That can be
interpreted as an increase in horizontal exploration activity, although
no effects were observed with Epoxy 1 and Epoxy 2 administrations.
Grooming and grooming ratio
The frequency and duration of each occurrence (when the animal
licks and scratches itself) was measured throughout the 300 sec of
testing. A significant increase in Grooming duration was observed only
with P microinfusion (428% compared to control; p<0.05; Figure 2c).
However, no significant effects were observed on the duration of each
Grooming event indicated by the “Grooming ratio” (defined like
Grooming duration/Grooming frequency; Figure 2d). No effects were
observed with the other three steroids in any of both variables.
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Rearing and rearing ratio
The frequency and duration of each occurrence (when the animal
stands up on its hind legs) was measured in the 300 sec of testing.
Significant increases in total Rearing duration were observed with A
and P treatments compared to vehicle (265% and 271% respectively;
p<0.05; Figure 2e). The increase of this parameter can be interpreted as
an augmentation of vertical exploration activity, although no effects
were observed on the duration of each Rearing event indicated by the
“Rearing ratio” (defined like Rearing duration/Rearing frequency;
Figure 2f). No effects were observed with Epoxy 1 and Epoxy 2
administrations in any of both parameters.
Figure 2: Unilateral microinfusion (0.3 µl) on dorsal hippocampus of vehicle (Veh., cylcodextrin 30% in aCSF) or steroid (A, P, Epoxy 1 and
Epoxy 2; 2 µg) and changes in open-field behavioral parameters: a Active time (difference between total time test and freezing in sec) b Line
crossing (number of grid lines crossed with all four paws), c Grooming (when the animal licks or scratches itself while stays still in sec) and d
ratio (duration/frequency) and e Rearing (when the animal stands up on its hind legs in sec), and f ratio (duration/frequency). Significant
effect was determined by one-way ANOVA: FActive time(4,35)=15.3; p<0.001, FLine crossing(4,35)=18.2; p<0.001, FGrooming(4,35)=2.8; p<0.05,
FGrooming ratio(4,24)=1.1; p=0.12, FRearing(4,35)=13.3; p<0.001 and FRearing ratio(4,28)=0.5; p=0.75, sub index in each F indicates the variable
analysed. *p<0.05 Newman-Keuls post hoc test.
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Correlation between Active time and Line crossing
Analysis of Line crossing variable based on Active time, showed a
positive correlation factor of 0.74, when all the treatments were
considered toghether (Figure 3 C). When this correlation was
performed for each treatment, significant effects of P and its analogue,
Epoxy 2 (r2=0.77 and r2=0.69 respectively; Figure 3 P and Figure 3
Epoxy 2) were observed, but with lower Active time for the Epoxy 2
than P. On the other hand, the Epoxy 1 showed similar pattern than its
natural analogue A and vehicle, with no significant ANOVA p values
(Figure 3).
Figure 3: Correlation between Line crossing and Active time behavioral parameters, under all conditions together (C) or for each
microinfusion treatment (Vehicle, A: allopregnanolone, P: pregnanolone, Epoxy 1 and Epoxy 2). Each point represents a value corresponding
to an individual animal test. Correlation coefficients are showed in each panel. Significant effects were determined by one-way ANOVA:
FC(1,40)=108.2; p<0.0001, FVehicle(1,6)=3.9; p=0.09, FA(1,6)=0.3; p=0.62, FP(1,6)=20.5; p=0.004, FEpoxy 1(1,6)=0.1; p=0.82 and FEpoxy 2
(1,6)=19.6; p=0.01, sub index in each F indicates the treatment analyzed. Dotted lines indicate the 95% confidence intervals.
Discussion
Anxiety is an unpleasant nervous state of inner restlessness.
Although benzodiazepines and barbiturates are among the treatments
of choice for this kind of pathologies, they may induce various side
effects [55]. Their actions may be mediated by the GABAA receptor
located within the hippocampal formation, which mediates
postsynaptic inhibition [56].
Progesterone and its reduced metabolites, A and P, were found to
produce anxiolytic-like effects similar to benzodiazepines [36,57,58].
In the brain, in situ synthetized NS are capable of modulating neuronal
excitability by rapid non-genomic actions [59] acting as potent
modulators of GABAA receptor-mediated neurotransmission [5]. They
can locally influence neuronal activity through their effects as
paracrine messengers [60]. Thus, NS may have important effects on the
regulation of the behavior in humans and in different murine models.
On the other hand, the hippocampal formation is important for the
acquisition of short-term memory [61] and it has been also related to
anxiety behaviors. Recently, reports described an association between
dorsal hippocampus and the modulation of anxiety behavior [39].
Moreover, other studies have shown a significant correlation between
low-anxiety or increased exploratory behaviors and A concentration in
the hippocampus [52]. Several studies developed in rodents show that
A and P reduce stress and anxiety-like behavior [1,36,62-67]. In fact,
the blockade of progesterone’s conversion to its metabolites impairs
social behavior and induces anxiety-related behavior in rats [68].
The SS arise as a promising solution to the poor bioavailability and
rapid metabolism of natural NS administration [12], but it is necessary
to compare their biological effects in similar targets and doses of the
NS.
In this work, an anxiety model developed to identify the
pharmacological mechanisms and potential clinical effects of synthetic
and natural steroids was used. Usually, this kind of model based on
conflict situations can generate opposite motivational states induced by
approach-avoidance situations, however it does not attempt to
replicate all features and symptoms of a specific anxiety disorder.
Rather, it tries to generate a state of anxiety that could be related to
these disorders. Another important methodological consideration that
needs to be taken into account is our choice to cannulate animals in a
unilateral way (with left/right alternations). Although bilateral
cannulae have been widely used to explore the anxiolytic and
antidepressant-like effects [46-48], we relied in reports that have not
found behavioral differences describing these effects between the brain
sides with unilateral progesterone or A microinfusions [49,50]. In
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agreement with this information, we do not observe lateral influence
on the horizontal and vertical exploratory activities either.
Here, we evaluated the anxiolytic properties of an equal dose of A, P
or two synthetic steroid analogues (Epoxy 1 and Epoxy 2) by
microinfusions in dorsal hippocampus on the open-field test,
quantifying horizontal and vertical exploration. The changes observed
on the behavioral parameters by A and P can be interpreted as
anxiolytic-like effects. Both natural NS enhanced the exploratory
activity observed trough the Line crossing, Grooming and Rearing
increases and Freezing decrease. However, in some cases P treatment
produced the most potent anxiolytic-like effects. Although anxiolytic
effects of A are widely described in literature [69-72], only few reports
have shown that P administration is able to produce similar effects
[28,36,57] with an improved efficacy in some cases [27].
Therefore, the results described in this work support these last
findings and add more evidence to this topic. Moreover, none of the
treatment affected the duration of Grooming and Rearing events
observed through the absence of significant differences in their ratios.
Although A and P treatments produce a significant increase in the
Active time and Line crossing, correlations analyses of Line crossing
based Active time were not equal. Only a positive correlation of these
parameters was observed with microinfusions of P or its analogue
Epoxy 2. These differences may probably due to the molecular features
of each steroid. These analyses allow to describe similar behavioral
effects for steroids with similar A/B rings conformations and suggest
that the SS and probably A doses should be administered in higher
concentrations to probably produce anxiolytic-like effects. Although,
these SS had a limited solubility in aqueous medium.
Previously, we described similar responses to A and P with these SS
administrations in a variety of assays, including binding modulation of
specific ligands to the GABAA receptor, the 3β-hydroxysteroid
dehydrogenase activity alteration and neuroprotection in cerebral
cortex and hippocampus cultures against a hypoxic event [17,18].
However, no effects were observed in these behavioral assays, we do
not discard these SS for further in vivo evaluations that include
another doses and more behavioral assays.
Summarizing, in this work we evaluated, in an open-field test, the in
vivo anxiolytic-like effects of two synthetic analogues of A and P with a
decreased molecular flexibility (that confers a favorable spatial
arrangement for the steroid binding site). Only an increase in animal
exploratory activities interpreted as anxiolytic-like effects were
observed with A and P microinfusions. The lack of anxiolytic-like
effect at the dose evaluated, and the previously reported modulation on
the GABAA receptor [17,18] may these SS suitable for therapeutical
treatments in other mood disorders where the GABAergic function is
involved like early chronic psychosocial stress or depression.
Nevertheless the action of these Epoxies should be further evaluated
for these conditions.
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